Clinical Trial

PMCF Investigation of MODULITH® SLX-F2 With StorM-Track in Patients With Kidney Stones

Recruiting
View on ClinicalTrials.gov →
Summary
Extracorporeal shockwave lithotripsy (ESWL) is a non-invasive standard treatment for kidney stones. This study will be conducted to evaluate the effectiveness of ESWL using MODULITH® SLX-F2 with stone tracking, compared to MODULITH® SLX-F2 without stone tracking, in adult patients with kidney stones, as measured by stone-free status.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-11-26; most recent amendment 2026-06-24.
Trial Details
NCT Number NCT07272720
Lead Sponsor Storz Medical AG
Collaborators: Karolinska University Hospital
Conditions Kidney Stones, Urolithiasis
Enrollment 126 participants
Start Date 2025-12-11
Primary Completion 2027-12 (estimated)
Study Completion 2028-10 (estimated)
Updated on ClinicalTrials.gov 2026-06-29